# PRD Quality Review — SiAGA Bunda

## Overall verdict

The PRD is fit to feed UX and architecture: it has a coherent thesis, explicit scope, contiguous requirements, testable consequences, and honest external launch gates. It does not pretend that software controls prove research or clinical validity. Remaining uncertainty is concentrated in accountable Study approvals and configurable technical mechanisms rather than hidden product behavior.

## Decision-readiness — adequate

The central decisions are explicit: Android-only MVP, 168 elapsed hours, backend authority, pseudonymous monitoring, controlled export, immutable Source Records, and an educational—not diagnostic—boundary. Section 10 names external gates without allowing them to leak into silent implementation assumptions.

### Findings

- **medium** External approval package is not available (§10) — Recruitment cannot begin until owners, protocol, ethics, instruments, content, data governance, and urgent-care contacts are approved. *Fix:* Keep real Participant data disabled through configuration activation and readiness/release gates; track these as external dependencies.

## Substance over theater — strong

The journeys drive concrete requirements, NFRs have product-specific bounds, and safety/privacy requirements materially change collection, export, playback, and withdrawal behavior. No novelty, persona, or compliance claims are used as decoration.

## Strategic coherence — strong

Every feature serves the narrow thesis of protocol adherence plus traceability without sacrificing Participant autonomy. Success metrics test invariants and auditability, while counter-metrics explicitly prevent gaming completion, watch time, deviations, and researcher convenience.

## Done-ness clarity — adequate

All 36 FRs have acceptance criteria. Cross-cutting requirements define measurable security, durability, performance, accessibility, compatibility, reliability, and testing expectations.

### Findings

- **medium** Architecture-owned numeric policies remain intentionally unset (§4 FR-15, §5 NFR-10) — Playback tolerance and operational alert thresholds require system design and load/error evidence. *Fix:* Architecture must define bounded defaults and verification tests without weakening FR-15 or safe-failure rules.
- **low** Study-configured late behavior is not numeric (§4 FR-20) — This is correctly reserved for the approved Study Protocol but must not become an unbounded implementation default. *Fix:* Require configuration activation to reject a missing late window.

## Scope honesty — strong

Non-goals explicitly exclude clinical care, iOS, uncontrolled offline completion, Source Record mutation, unrestricted export, general platform scope, and effectiveness claims. The Assumptions Index has no unresolved product assumptions, while external gates remain plainly visible.

## Downstream usability — strong

UJ-1 through UJ-5 and FR-1 through FR-36 are contiguous and stable. Glossary terms anchor state, timing, records, roles, and safety boundaries. Each requirement can be extracted independently with its acceptance criteria.

## Shape fit — strong

The chain-top, regulated, two-surface mobile product warrants journeys, feature-grouped FRs, cross-cutting NFRs, governance, failure states, metrics, and explicit launch gates. Technical mechanism choices are correctly placed in the addendum for architecture.

## Mechanical notes

- FR IDs are contiguous from FR-1 through FR-36; UJ IDs are contiguous from UJ-1 through UJ-5.
- No duplicate Success Metric IDs remain.
- No unresolved inline `[ASSUMPTION]` tags remain; the Assumptions Index round-trips correctly.
- Relative links to blueprint, brief, and brief addendum resolve from the PRD workspace.
